NCT06088017

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391(2)

A Phase I Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics After Administration of CKD-391(2) and Co-administration of CKD-331 and D337 in Healthy Adult Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 66 (actual)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: All
• Age: 19 Years – 55 Years
• Healthy volunteers: Accepted

Summary

A clinical trial to compare and evaluate the safety and pharmacokinetics of CKD-391(2)

Detailed description

A phase I clinical trial to compare and evaluate the safety and pharmacokinetic characteristics after administration of CKD-391(2) and co-administration of CKD-331 and D337 in healthy adult volunteers

Conditions

• Dyslipidemias

Interventions

Type	Name	Description
DRUG	CKD-391(2)	QD, PO
DRUG	CKD-331, D337	QD, PO

Timeline

• Start date: 2023-10-23
• Primary completion: 2024-01-07
• Completion: 2024-01-22
• First posted: 2023-10-18
• Last updated: 2024-03-27

Locations

1 site across 1 country: South Korea